Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011

Drug and Alcohol Review

Volumn 33, Issue 1, 2014, Pages 19-26

  Fischer, Benedikt ^a,b,c   Jones, Wayne ^a   Urbanoski, Karen ^b,c   Skinner, Roger ^d   Rehm, Jürgen ^b,c,e  

^a SIMON FRASER UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Ministry of Community Safety and Correctional Services   (Canada)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Canada.; Morbidity; Mortality; Population health; Prescription opioid

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

CANADA; DRUG OVERDOSE; DRUG UTILIZATION; EPIDEMIOLOGY; HUMAN; MORTALITY; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TRENDS;

ANALGESICS, OPIOID; DRUG OVERDOSE; DRUG UTILIZATION; HUMANS; ONTARIO; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS;

EID: 84891934085     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12089     Document Type: Article

References (44)

1. Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician 2012;15(3 Suppl):ES191-203.
2. Manchikanti L, Helm S, Fellows B, etal. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9-38.
3. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-659.
4. Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment Episode Data Set (TEDS) 2000-2010 national admissions for substance abuse treatment services. DASIS series S-61, HHS publication No. (SMA) 12-4701. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012.
5. Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-39, HHS Publication No. (SMA) 13-4760. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
6. Fischer B, Nakamura N, Rush B, Rehm J, Urbanoski K. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend 2010;109:257-260.
7. Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada. PLoS ONE 2013;8:e60600.
8. Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004;5:59-65.
9. Dasgupta N, Kramer ED, Zalman MA, etal. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006;82:135-142.
10. Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007;16:827-840.
11. Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 2008;27:1-11.
12. Gomes T, Juurlink DN, Moineddin R, etal. Geographical variation in opioid prescribing and opioid-related mortality in ontario. Healthc Q 2011;14:22-24.
13. Reifler LM, Droz D, Bailey JE, etal. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med 2012;13:434-442.
14. Fischer B, Nakamura N, Urbanoski K, Rush B, Rehm J. Correlations between population levels of prescription opioid use and prescription opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health 2012;126:749-751.
15. Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiol Drug Saf 2013;22:438-442.
16. Modarai F, Mack K, Hicks P, etal. Relationship of opioid prescription sales and overdoses, North Carolina. Drug Alcohol Depend 2013;132:81-86.
17. Leon D, McCambridge J. Liver cirrhosis mortality rates in Britain, 1950 to 2002. Lancet 2006;367:52-56.
18. Livingston M, Wilkinson C. Per-capita alcohol consumption and all-cause male mortality in Australia, 1911-2006. Alcohol Alcohol 2013;48:196-201.
19. International Narcotics Control Board (INCB). Narcotic drugs technical report: estimated world requirements for 2013-statistics for 2011. T.13.XI.2. New York, NY: United Nations, 2013.
20. National Advisory Council on Prescription Drug Misuse. First do no harm: responding to Canada's prescription drug crisis (report in short). (2013). Available at: http://www.ccsa.ca/2013%20CCSA%20Documents/Canada-Strategy-Prescription-Drug-Misuse-Summary-en.pdf (accessed June 28 2013).
21. Fischer B, Keates A. 'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting Oxycontin in Canada. Int J Drug Policy 2012;23:495-497.
22. Drug and Alcohol Treatment Information System (DATIS). Substance abuse statistical tables: fiscal year 2007/2008 to fiscal year 2011/2012. Toronto, ON: Centre for Addiction & Mental Health, 2012.
23. IMS Brogan (IMSB). IMSB Canadian compuscript audit. (2010). Available at: http://imsbrogansolutions.com/main.php?t=services&i=6 (accessed May 9 2013).
24. Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 2011;20:1269-1277.
25. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index (2013). Available at: http://www.whocc.no/atc_ddd_index/ (accessed May 9 2013).
26. Office of the Chief Coroner of Ontario. Office of the chief coroner report for 2009-2011. Toronto, ON: Ministry of Community Safety and Correctional Services, 2012.
27. Fischer B, Ialomiteanu A, Boak A, Adlaf E, Rehm J, Mann R. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev 2013;32:276-287.
28. Braden JB, Russo J, Fan M, etal. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170:1425-1432.
29. Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11:490-518.
30. Expert Working Group on Narcotic Addiction. The way forward: stewardship for prescription narcotics in Ontario. Ontario: Ontario Ministry of Health and Long-Term Care, 2012.
31. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012;308:1865-1866.
32. Lohman D, Schleifer R, Amon JJ. Access to pain treatment as a human right. BMC Med 2010;8:8.
33. Lynch ME. The need for a Canadian Pain Strategy. Pain Res Manag 2011;16:77-80.
34. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171:686-691.
35. Bohnert ASB, Valenstein M, Bair MJ, etal. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-1321.
36. Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008;11(2 Suppl):S181-200.
37. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008;24:469-478.
38. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: time to back off? J Am Board Fam Med 2009;22:62-68.
39. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:147-159.
40. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med 2012;55:325-331.
41. Chou R, Fanciullo G, Fine P, etal. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-130.
42. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. (2010). Available at: http://nationalpaincentre.mcmaster.ca/opioid/documents.html (accessed October 15 2013).
43. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ 2011;343:d5142.
44. Rotondi NK, Rush B. Monitoring utilization of a large scale addiction treatment system: the Drug and Alcohol Treatment Information System (DATIS). Subst Abuse 2012;6:73-84.